Selected research
Market Outlook & Growth Opportunities
Global Memantine Market Outlook and Growth Opportunities 2026
Market perspective
The global Memantine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Memantine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Memantine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Memantine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Memantine market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Memantine market include Eisai Co, Johnson & Johnson, Novartis AG, Ono Pharmaceutical Co Ltd, H Lundbeck A/S, Daiichi Sankyo Company Limited and Allergan, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Memantine market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Memantine and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Memantine revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Memantine market.
Memantine Segment by Company
Eisai Co
Johnson & Johnson
Novartis AG
Ono Pharmaceutical Co Ltd
H Lundbeck A/S
Daiichi Sankyo Company Limited
Allergan
Memantine Segment by Type
Memantine Powder
Memantine Capsule
Memantine Tablet
Memantine Segment by Application
Hospital Pharmacy
Retail Pharmacy
Memantine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Memantine status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Memantine key companies, revenue, market share, and recent developments.
3. To split the Memantine breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Memantine market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Memantine significant trends, drivers, influence factors in global and regions.
6. To analyze Memantine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Memantine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Memantine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Memantine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Memantine industry.
Chapter 3: Detailed analysis of Memantine company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Memantine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Memantine in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Memantine Powder
- Memantine Capsule
- Memantine Tablet
Applications
- Hospital Pharmacy
- Retail Pharmacy
Companies covered
- Eisai Co
- Johnson & Johnson
- Novartis AG
- Ono Pharmaceutical Co Ltd
- H Lundbeck A/S
- Daiichi Sankyo Company Limited
- Allergan
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Memantine Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Memantine Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Memantine Market Dynamics
- 2.1 Memantine Industry Trends
- 2.2 Memantine Industry Drivers
- 2.3 Memantine Industry Opportunities and Challenges
- 2.4 Memantine Industry Restraints
3 Memantine Market by Company
- 3.1 Global Memantine Company Revenue Ranking in 2025
- 3.2 Global Memantine Revenue by Company (2021-2026)
- 3.3 Global Memantine Company Ranking (2024-2026)
- 3.4 Global Memantine Company Manufacturing Base and Headquarters
- 3.5 Global Memantine Company Product Type and Application
- 3.6 Global Memantine Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Memantine Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Memantine Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Memantine Market by Type
- 4.1 Memantine Type Introduction
- 4.1.1 Memantine Powder
- 4.1.2 Memantine Capsule
- 4.1.3 Memantine Tablet
- 4.2 Global Memantine Sales Value by Type
- 4.2.1 Global Memantine Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Memantine Sales Value by Type (2021-2032)
- 4.2.3 Global Memantine Sales Value Share by Type (2021-2032)
5 Memantine Market by Application
- 5.1 Memantine Application Introduction
- 5.1.1 Hospital Pharmacy
- 5.1.2 Retail Pharmacy
- 5.2 Global Memantine Sales Value by Application
- 5.2.1 Global Memantine Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Memantine Sales Value by Application (2021-2032)
- 5.2.3 Global Memantine Sales Value Share by Application (2021-2032)
6 Memantine Regional Value Analysis
- 6.1 Global Memantine Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Memantine Sales Value by Region (2021-2032)
- 6.2.1 Global Memantine Sales Value by Region: 2021-2026
- 6.2.2 Global Memantine Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Memantine Sales Value (2021-2032)
- 6.3.2 North America Memantine Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Memantine Sales Value (2021-2032)
- 6.4.2 Europe Memantine Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Memantine Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Memantine Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Memantine Sales Value (2021-2032)
- 6.6.2 South America Memantine Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Memantine Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Memantine Sales Value Share by Country, 2025 VS 2032
7 Memantine Country-level Value Analysis
- 7.1 Global Memantine Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Memantine Sales Value by Country (2021-2032)
- 7.2.1 Global Memantine Sales Value by Country (2021-2026)
- 7.2.2 Global Memantine Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Memantine Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Memantine Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Memantine Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Memantine Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Memantine Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Memantine Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Memantine Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Memantine Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Memantine Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Memantine Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Memantine Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Memantine Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Memantine Sales Value Growth Rate (2021-2032)
- 7.7.2 France Memantine Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Memantine Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Memantine Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Memantine Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Memantine Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Memantine Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Memantine Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Memantine Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Memantine Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Memantine Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Memantine Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Memantine Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Memantine Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Memantine Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Memantine Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Memantine Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Memantine Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Memantine Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Memantine Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Memantine Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Memantine Sales Value Growth Rate (2021-2032)
- 7.14.2 China Memantine Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Memantine Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Memantine Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Memantine Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Memantine Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Memantine Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Memantine Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Memantine Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Memantine Sales Value Growth Rate (2021-2032)
- 7.17.2 India Memantine Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Memantine Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Memantine Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Memantine Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Memantine Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Memantine Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Memantine Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Memantine Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Memantine Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Memantine Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Memantine Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Memantine Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Memantine Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Memantine Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Memantine Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Memantine Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Memantine Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Memantine Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Memantine Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Memantine Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Memantine Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Memantine Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Memantine Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Memantine Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Memantine Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Memantine Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Memantine Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Memantine Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Memantine Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Memantine Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Memantine Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Memantine Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Memantine Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Memantine Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Memantine Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Memantine Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Memantine Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Memantine Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Memantine Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Memantine Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Memantine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Eisai Co
- 8.1.1 Eisai Co Company Information
- 8.1.2 Eisai Co Business Overview
- 8.1.3 Eisai Co Memantine Revenue and Gross Margin (2021-2026)
- 8.1.4 Eisai Co Memantine Product Portfolio
- 8.1.5 Eisai Co Recent Developments
- 8.2 Johnson & Johnson
- 8.2.1 Johnson & Johnson Company Information
- 8.2.2 Johnson & Johnson Business Overview
- 8.2.3 Johnson & Johnson Memantine Revenue and Gross Margin (2021-2026)
- 8.2.4 Johnson & Johnson Memantine Product Portfolio
- 8.2.5 Johnson & Johnson Recent Developments
- 8.3 Novartis AG
- 8.3.1 Novartis AG Company Information
- 8.3.2 Novartis AG Business Overview
- 8.3.3 Novartis AG Memantine Revenue and Gross Margin (2021-2026)
- 8.3.4 Novartis AG Memantine Product Portfolio
- 8.3.5 Novartis AG Recent Developments
- 8.4 Ono Pharmaceutical Co Ltd
- 8.4.1 Ono Pharmaceutical Co Ltd Company Information
- 8.4.2 Ono Pharmaceutical Co Ltd Business Overview
- 8.4.3 Ono Pharmaceutical Co Ltd Memantine Revenue and Gross Margin (2021-2026)
- 8.4.4 Ono Pharmaceutical Co Ltd Memantine Product Portfolio
- 8.4.5 Ono Pharmaceutical Co Ltd Recent Developments
- 8.5 H Lundbeck A/S
- 8.5.1 H Lundbeck A/S Company Information
- 8.5.2 H Lundbeck A/S Business Overview
- 8.5.3 H Lundbeck A/S Memantine Revenue and Gross Margin (2021-2026)
- 8.5.4 H Lundbeck A/S Memantine Product Portfolio
- 8.5.5 H Lundbeck A/S Recent Developments
- 8.6 Daiichi Sankyo Company Limited
- 8.6.1 Daiichi Sankyo Company Limited Company Information
- 8.6.2 Daiichi Sankyo Company Limited Business Overview
- 8.6.3 Daiichi Sankyo Company Limited Memantine Revenue and Gross Margin (2021-2026)
- 8.6.4 Daiichi Sankyo Company Limited Memantine Product Portfolio
- 8.6.5 Daiichi Sankyo Company Limited Recent Developments
- 8.7 Allergan
- 8.7.1 Allergan Company Information
- 8.7.2 Allergan Business Overview
- 8.7.3 Allergan Memantine Revenue and Gross Margin (2021-2026)
- 8.7.4 Allergan Memantine Product Portfolio
- 8.7.5 Allergan Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst